共 50 条
- [1] Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung CancerCLINICAL LUNG CANCER, 2018, 19 (06) : E893 - E900Owen, Dwight H.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Wexner Med Ctr, James Canc Hosp & Solove Res Inst, Div Med Oncol, 320 West 10th Ave,A450B Starling Loving Hall, Columbus, OH 43210 USA Ohio State Univ, Wexner Med Ctr, James Canc Hosp & Solove Res Inst, Div Med Oncol, 320 West 10th Ave,A450B Starling Loving Hall, Columbus, OH 43210 USAWei, Lai论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Wexner Med Ctr, James Canc Hosp & Solove Res Inst, Ctr Biostat, Columbus, OH 43210 USA Ohio State Univ, Wexner Med Ctr, James Canc Hosp & Solove Res Inst, Div Med Oncol, 320 West 10th Ave,A450B Starling Loving Hall, Columbus, OH 43210 USABertino, Erin M.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Wexner Med Ctr, James Canc Hosp & Solove Res Inst, Div Med Oncol, 320 West 10th Ave,A450B Starling Loving Hall, Columbus, OH 43210 USA Ohio State Univ, Wexner Med Ctr, James Canc Hosp & Solove Res Inst, Div Med Oncol, 320 West 10th Ave,A450B Starling Loving Hall, Columbus, OH 43210 USAEdd, Thomas论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Wexner Med Ctr, Dept Internal Med, Columbus, OH 43210 USA Ohio State Univ, Wexner Med Ctr, James Canc Hosp & Solove Res Inst, Div Med Oncol, 320 West 10th Ave,A450B Starling Loving Hall, Columbus, OH 43210 USAVillalona-Calero, Miguel A.论文数: 0 引用数: 0 h-index: 0机构: Miami Canc Inst, Miami, FL USA Ohio State Univ, Wexner Med Ctr, James Canc Hosp & Solove Res Inst, Div Med Oncol, 320 West 10th Ave,A450B Starling Loving Hall, Columbus, OH 43210 USAHe, Kai论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Wexner Med Ctr, James Canc Hosp & Solove Res Inst, Div Med Oncol, 320 West 10th Ave,A450B Starling Loving Hall, Columbus, OH 43210 USA Ohio State Univ, Wexner Med Ctr, James Canc Hosp & Solove Res Inst, Div Med Oncol, 320 West 10th Ave,A450B Starling Loving Hall, Columbus, OH 43210 USAShields, Peter G.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Wexner Med Ctr, James Canc Hosp & Solove Res Inst, Div Med Oncol, 320 West 10th Ave,A450B Starling Loving Hall, Columbus, OH 43210 USA Ohio State Univ, Wexner Med Ctr, James Canc Hosp & Solove Res Inst, Div Med Oncol, 320 West 10th Ave,A450B Starling Loving Hall, Columbus, OH 43210 USACarbone, David P.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Wexner Med Ctr, James Canc Hosp & Solove Res Inst, Div Med Oncol, 320 West 10th Ave,A450B Starling Loving Hall, Columbus, OH 43210 USA Ohio State Univ, Wexner Med Ctr, James Canc Hosp & Solove Res Inst, Div Med Oncol, 320 West 10th Ave,A450B Starling Loving Hall, Columbus, OH 43210 USAOtterson, Gregory A.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Wexner Med Ctr, James Canc Hosp & Solove Res Inst, Div Med Oncol, 320 West 10th Ave,A450B Starling Loving Hall, Columbus, OH 43210 USA Ohio State Univ, Wexner Med Ctr, James Canc Hosp & Solove Res Inst, Div Med Oncol, 320 West 10th Ave,A450B Starling Loving Hall, Columbus, OH 43210 USA
- [2] Incidence of endocrine-related immune-related adverse events in Japanese subjects with various types of cancerFRONTIERS IN ENDOCRINOLOGY, 2023, 14Iwamoto, Yuichiro论文数: 0 引用数: 0 h-index: 0机构: Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, Japan Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, JapanKimura, Tomohiko论文数: 0 引用数: 0 h-index: 0机构: Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, Japan Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, JapanIwamoto, Hideyuki论文数: 0 引用数: 0 h-index: 0机构: Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, Japan Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, JapanSanada, Junpei论文数: 0 引用数: 0 h-index: 0机构: Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, Japan Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, JapanFushimi, Yoshiro论文数: 0 引用数: 0 h-index: 0机构: Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, Japan Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, JapanKatakura, Yukino论文数: 0 引用数: 0 h-index: 0机构: Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, Japan Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, JapanTatsumi, Fuminori论文数: 0 引用数: 0 h-index: 0机构: Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, Japan Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, JapanShimoda, Masashi论文数: 0 引用数: 0 h-index: 0机构: Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, Japan Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, JapanNakanishi, Shuhei论文数: 0 引用数: 0 h-index: 0机构: Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, Japan Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, JapanMune, Tomoatsu论文数: 0 引用数: 0 h-index: 0机构: Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, Japan Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, JapanKaku, Kohei论文数: 0 引用数: 0 h-index: 0机构: Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, Japan Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, JapanKaneto, Hideaki论文数: 0 引用数: 0 h-index: 0机构: Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, Japan Kawasaki Med Sch, Div Diabet Endocrinol & Metab, Kurashiki, Japan
- [3] Risk factors for immune related adverse events: A retrospective studyANNALS OF ONCOLOGY, 2019, 30Parmanande, A. Q.论文数: 0 引用数: 0 h-index: 0机构: HSAC, CHLC, Oncol Med, Lisbon, Portugal HSAC, CHLC, Oncol Med, Lisbon, PortugalBarreira, J. V.论文数: 0 引用数: 0 h-index: 0机构: HSAC, CHLC, Oncol Med, Lisbon, Portugal HSAC, CHLC, Oncol Med, Lisbon, PortugalSpencer, A. S.论文数: 0 引用数: 0 h-index: 0机构: HSAC, CHLC, Oncol Med, Lisbon, Portugal HSAC, CHLC, Oncol Med, Lisbon, PortugalReis, A. F.论文数: 0 引用数: 0 h-index: 0机构: HSAC, CHLC, Oncol Med, Lisbon, Portugal HSAC, CHLC, Oncol Med, Lisbon, PortugalSardinha, M.论文数: 0 引用数: 0 h-index: 0机构: HSAC, CHLC, Oncol Med, Lisbon, Portugal HSAC, CHLC, Oncol Med, Lisbon, PortugalSimao, D. C.论文数: 0 引用数: 0 h-index: 0机构: HSAC, CHLC, Oncol Med, Lisbon, Portugal HSAC, CHLC, Oncol Med, Lisbon, PortugalLuz, R.论文数: 0 引用数: 0 h-index: 0机构: HSAC, CHLC, Oncol Med, Lisbon, Portugal HSAC, CHLC, Oncol Med, Lisbon, Portugal
- [4] Risk profiles and incidence of cardiovascular events across different cancer typesESMO OPEN, 2023, 8 (06)Mitchell, J. D.论文数: 0 引用数: 0 h-index: 0机构: Washington Univ St Louis, Cardiooncol Ctr Excellence, St Louis, MO USA Int Cardiooncol Soc, Tampa, FL USA Washington Univ, Sch Med, Cardiovasc Div, Cardiooncol Ctr Excellence, Campus Box 8086,660 South Euclid Ave, St Louis, MO 63110 USA Washington Univ St Louis, Cardiooncol Ctr Excellence, St Louis, MO USALaurie, M.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Lawrenceville, NJ USA Washington Univ St Louis, Cardiooncol Ctr Excellence, St Louis, MO USAXia, Q.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Lawrenceville, NJ USA Washington Univ St Louis, Cardiooncol Ctr Excellence, St Louis, MO USADreyfus, B.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Lawrenceville, NJ USA Washington Univ St Louis, Cardiooncol Ctr Excellence, St Louis, MO USAJain, N.论文数: 0 引用数: 0 h-index: 0机构: Mu Sigma, Northbrook, IL USA Washington Univ St Louis, Cardiooncol Ctr Excellence, St Louis, MO USAJain, A.论文数: 0 引用数: 0 h-index: 0机构: Mu Sigma, Northbrook, IL USA Washington Univ St Louis, Cardiooncol Ctr Excellence, St Louis, MO USALane, D.论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Lawrenceville, NJ USA Washington Univ St Louis, Cardiooncol Ctr Excellence, St Louis, MO USALenihan, D. J.论文数: 0 引用数: 0 h-index: 0机构: Int Cardiooncol Soc, Tampa, FL USA St Francis Healthcare, Cape Girardeau, MO USA Washington Univ St Louis, Cardiooncol Ctr Excellence, St Louis, MO USA
- [5] Phenotypic insights into genetic risk factors for immune-related adverse events in cancer immunotherapyCANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 74 (01)Ma, Haochuan论文数: 0 引用数: 0 h-index: 0机构: Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Dept Oncol, Guangzhou, Guangdong, Peoples R China Guangdong Prov Hosp, Chinese Med Postdoctoral Res Workstn, Guangzhou, Guangdong, Peoples R China Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Dept Oncol, Guangzhou, Guangdong, Peoples R ChinaSong, Dili论文数: 0 引用数: 0 h-index: 0机构: Cent Hosp Guangdong Prov Nongken, Integrated Chinese & Westeern Treatment Oncol Dept, Zhanjiang, Guangdong, Peoples R China Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Dept Oncol, Guangzhou, Guangdong, Peoples R ChinaZhang, Haibo论文数: 0 引用数: 0 h-index: 0机构: Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Dept Oncol, Guangzhou, Guangdong, Peoples R China Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Dept Oncol, Guangzhou, Guangdong, Peoples R ChinaLi, Taidong论文数: 0 引用数: 0 h-index: 0机构: Cent Hosp Guangdong Prov Nongken, Integrated Chinese & Westeern Treatment Oncol Dept, Zhanjiang, Guangdong, Peoples R China Cent Hosp Guangdong Prov Nongken, Dept Thorac Surg, Zhanjiang, Guangdong, Peoples R China Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Dept Oncol, Guangzhou, Guangdong, Peoples R ChinaJin, Xing论文数: 0 引用数: 0 h-index: 0机构: Yangzhou Univ, Dept Lab Med, Affiliated Hosp, Yangzhou, Jiangsu, Peoples R China Guangzhou Univ Chinese Med, Guangdong Prov Hosp Chinese Med, Affiliated Hosp 2, Dept Oncol, Guangzhou, Guangdong, Peoples R China
- [6] Baseline risk factors associated with immune related adverse events and atezolizumabFRONTIERS IN ONCOLOGY, 2023, 13Madjar, Katrin论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche, Prod Dev PD, Basel, Switzerland F Hoffmann La Roche, Prod Dev PD, Basel, SwitzerlandMohindra, Rajat论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche, Prod Dev PD, Basel, Switzerland F Hoffmann La Roche, Prod Dev PD, Basel, SwitzerlandDuran-Pacheco, Gonzalo论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche, Prod Dev PD, Basel, Switzerland F Hoffmann La Roche, Prod Dev PD, Basel, SwitzerlandRasul, Rashad论文数: 0 引用数: 0 h-index: 0机构: Bristol Myers Squibb, Stat Programming & Technol, Basel, Switzerland F Hoffmann La Roche, Prod Dev PD, Basel, SwitzerlandEssioux, Laurent论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche, Prod Dev PD, Basel, Switzerland F Hoffmann La Roche, Prod Dev PD, Basel, SwitzerlandMaiya, Vidya论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, Prod Dev PD, South San Francisco, CA USA F Hoffmann La Roche, Prod Dev PD, Basel, SwitzerlandChandler, G. Scott论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche, Prod Dev PD, Basel, Switzerland F Hoffmann La Roche, Prod Dev PD, Basel, Switzerland
- [7] Small Cell Lung Cancer Immune Related Adverse Events, Survival ImpactsJOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S692 - S692Hunting, J. C.论文数: 0 引用数: 0 h-index: 0机构: Wake Forest Sch Med, Winston Salem, NC USA Wake Forest Sch Med, Winston Salem, NC USAOlson, E.论文数: 0 引用数: 0 h-index: 0机构: Wake Forest Sch Med, Winston Salem, NC USA Wake Forest Sch Med, Winston Salem, NC USAFaucheux, A.论文数: 0 引用数: 0 h-index: 0机构: Wake Forest Sch Med, Winston Salem, NC USA Wake Forest Sch Med, Winston Salem, NC USAPrice, S.论文数: 0 引用数: 0 h-index: 0机构: Wake Forest Sch Med, Winston Salem, NC USA Wake Forest Sch Med, Winston Salem, NC USAElko, C.论文数: 0 引用数: 0 h-index: 0机构: Wake Forest Sch Med, Winston Salem, NC USA Wake Forest Sch Med, Winston Salem, NC USAQuattlebaum, A.论文数: 0 引用数: 0 h-index: 0机构: Wake Forest Sch Med, Winston Salem, NC USA Wake Forest Sch Med, Winston Salem, NC USALycan, T.论文数: 0 引用数: 0 h-index: 0机构: Wake Forest Sch Med, Winston Salem, NC USA Wake Forest Sch Med, Winston Salem, NC USA
- [8] Risk factors associated with immune-related severe adverse events in patients with cancer: A scoping reviewASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2025, 12Su, Zhenzhen论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Sch Nursing, Beijing, Peoples R China Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China Peking Univ, Sch Nursing, Beijing, Peoples R ChinaZhang, Liyan论文数: 0 引用数: 0 h-index: 0机构: Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Key Lab Carcinogenesis & Translat Res, Minist Educ, Beijing, Peoples R China Peking Univ, Sch Nursing, Beijing, Peoples R ChinaLian, Xuemin论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Sch Nursing, Beijing, Peoples R China Tianjin Med Univ, Gen Hosp, Dept Hlth & Med, Tianjin, Peoples R China Peking Univ, Sch Nursing, Beijing, Peoples R ChinaWang, Yixuan论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Sch Nursing, Beijing, Peoples R China Peking Univ, Sch Nursing, Beijing, Peoples R China
- [9] Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancerNature Cancer, 2023, 4 : 844 - 859Changhwan Sung论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringJinhyeon An论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringSoohyeon Lee论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringJaesoon Park论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringKang Seon Lee论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringIl-Hwan Kim论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringJi-Youn Han论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringYeon Hee Park论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringJee Hyun Kim论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringEun Joo Kang论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringMin Hee Hong论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringTae-Yong Kim论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringJae Cheol Lee论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringJae Lyun Lee论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringShinkyo Yoon论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringChang-Min Choi论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringDae Ho Lee论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringChanghoon Yoo论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringSang-We Kim论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringJae Ho Jeong论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringSeyoung Seo论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringSun Young Kim论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringSun-Young Kong论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringJung Kyoon Choi论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain EngineeringSook Ryun Park论文数: 0 引用数: 0 h-index: 0机构: KAIST,Department of Bio and Brain Engineering
- [10] Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancerNATURE CANCER, 2023, 4 (06) : 844 - +Sung, Changhwan论文数: 0 引用数: 0 h-index: 0机构: Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea Univ Ulsan, Asan Med Ctr, Dept Nucl Med, Coll Med, Seoul, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South KoreaAn, Jinhyeon论文数: 0 引用数: 0 h-index: 0机构: Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South KoreaLee, Soohyeon论文数: 0 引用数: 0 h-index: 0机构: Korea Univ, Anam Hosp, Dept Internal Med, Coll Med,Div Oncol Hematol, Seoul, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South KoreaPark, Jaesoon论文数: 0 引用数: 0 h-index: 0机构: Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South KoreaLee, Kang Seon论文数: 0 引用数: 0 h-index: 0机构: Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South KoreaKim, Il-Hwan论文数: 0 引用数: 0 h-index: 0机构: Inje Univ, Haeundae Paik Hosp, Canc Ctr, Coll Med,Dept Oncol, Busan, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South KoreaHan, Ji-Youn论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Ctr Lung Canc, Goyang, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South KoreaPark, Yeon Hee论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Samsung Med Ctr, Dept Med, Sch Med,Div Hematol Oncol, Seoul, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South KoreaKim, Jee Hyun论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med,Div Hematol & Med Oncol, Seongnam, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South KoreaKang, Eun Joo论文数: 0 引用数: 0 h-index: 0机构: Korea Univ, Guro Hosp, Dept Internal Med, Coll Med,Div Oncol, Seoul, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South KoreaHong, Min Hee论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Yonsei Canc Ctr, Dept Internal Med, Coll Med,Div Med Oncol, Seoul, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South KoreaKim, Tae-Yong论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Coll Med,Div Hematol & Med Oncol, Seoul, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South KoreaLee, Jae Cheol论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South KoreaLee, Jae Lyun论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South KoreaYoon, Shinkyo论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South KoreaChoi, Chang-Min论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Kim, Sang-We论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea论文数: 引用数: h-index:机构:Seo, Seyoung论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea论文数: 引用数: h-index:机构:Kong, Sun-Young论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Res Inst, Targeted Therapy Branch, Goyang, South Korea Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Biomed Sci, Goyang, South Korea Hosp Natl Canc Ctr, Dept Lab Med, Goyang, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South KoreaChoi, Jung Kyoon论文数: 0 引用数: 0 h-index: 0机构: Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea Penta Medix Co Ltd, Seongnam, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South KoreaPark, Sook Ryun论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Asan Med Ctr, Dept Oncol, Coll Med, Seoul, South Korea Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea